McDade

DGAP-News: G Medical Innovations Joins Forces with Serology Covid Testing to Support Safer Classroom Learning in California School Districts Amid Omicron Variant Surge

Retrieved on: 
Thursday, January 27, 2022 - 7:45pm

On average, G Medical expects to collect an average of $197.88 per patient encounter, which could amount to more than $1,000,000 in gross revenue per week.

Key Points: 
  • On average, G Medical expects to collect an average of $197.88 per patient encounter, which could amount to more than $1,000,000 in gross revenue per week.
  • This relationship is especially meaningful to us because our testing services are now endorsed by a pioneering healthcare company," said Caroline Grotewiel, CEO of Serology Covid Testing.
  • "G Medical has long been at the forefront of medical devices, offering remote patient monitoring tools to help keep patients healthy.
  • If you are interested in offering your school free on-site COVID-19 testing services, please contact Andrew Benavente at Serology Covid Testing; +1 310-747-5473; Andrew.m@Serology-Testing.com .

DGAP-News: Correction Notice to Press Release Regarding Personal Acquisitions of G Medical Shares in the Open Market

Retrieved on: 
Wednesday, January 19, 2022 - 8:24pm

Instead, Dr. Geva and Mr. McDade each intend to acquire stock in the open market following the announcement, during the next available trading window.

Key Points: 
  • Instead, Dr. Geva and Mr. McDade each intend to acquire stock in the open market following the announcement, during the next available trading window.
  • Founded in 1994, McDade Group is a growing and dynamic sales, marketing, and distribution services company headquartered in Pittsburgh, PA.
  • The company has expanded to provide solutions in distribution, category management, full-service merchandising, and consulting across the U.S. retail industry.
  • For example, G Medical is using forward-looking statements when it discusses the purchase of shares in the open market by Dr. Geva and Mr. McDade.

DGAP-News: G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations

Retrieved on: 
Friday, January 14, 2022 - 12:05pm

G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations

Key Points: 
  • G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations
    The issuer is solely responsible for the content of this announcement.
  • Dr. Yacov Geva, President and CEO of G Medical Innovations, and Michael McDade, CEO of McDade Products, LLC , announced today that they acquired an undisclosed number of shares of G Medical Innovations (NASDAQ: GMVD).
  • G Medical Tests and Services currently operates storefront testing locations in California.
  • During the next few months, the company expects to expand its network of storefront testing locations in California and other U.S. regions to be announced at a later date.

DGAP-News: McDade Products, LLC and G Medical Tests Secure Additional Purchase Order for $6.5 Million, Reflecting $3.5 Million Gross Margin, to be Delivered in Q1

Retrieved on: 
Wednesday, January 12, 2022 - 12:07pm

Secure Additional Purchase Order for $6.5 Million,

Key Points: 
  • Secure Additional Purchase Order for $6.5 Million,
    Reflecting $3.5 Million Gross Margin, to be Delivered in Q1
    The issuer is solely responsible for the content of this announcement.
  • PITTSBURGH, PA - McDade Products, LLC and G Medical Tests and Services, a division of G Medical Innovations Holdings Ltd. (NASDAQ: GMVD), today announced an additional $6.5 million purchase order for two million COVID-19 PCR collection test kits.
  • G Medical will be selling these units wholesale for $3.25 each, reflecting a gross profit of approximately $3.5 million.
  • G Medical Tests and Services is delighted to provide McDade with current and future purchase orders.

DGAP-News: McDade Products, LLC Joins Forces with G Medical Tests and Services to Provide U.S. Retailers with Millions of COVID-19 at-Home PCR Test Kits

Retrieved on: 
Monday, January 10, 2022 - 12:13pm

McDade Products is a division of McDade Group, a specialty sales, marketing, and distribution company serving the U.S. retail industry.

Key Points: 
  • McDade Products is a division of McDade Group, a specialty sales, marketing, and distribution company serving the U.S. retail industry.
  • McDade Products is now accepting orders for the co-branded LiveNow PCR Collection Kit, which will retail for $9.99.
  • The diagnostic PCR (polymerase chain reaction) test detects the presence or absence of SARS-CoV2, the virus that causes COVID-19.
  • On average, tests results are expected to be available online within 24 hours from the time the sample is received.

Maple Leaf Foods Partners with Alliance to Stop Foodborne Illness to Host 11th Food Safety Symposium

Retrieved on: 
Wednesday, October 27, 2021 - 8:07pm

MISSISSAUGA, ON, Oct. 27, 2021 /PRNewswire/ - Maple Leaf Foods (TSX: MFI) yesterday hosted its 11th Food Safety Symposium in partnership with the Alliance to Stop Foodborne Illness (STOP Alliance) as part of the company's ongoing commitment to enhance food safety across the global food supply chain.

Key Points: 
  • MISSISSAUGA, ON, Oct. 27, 2021 /PRNewswire/ - Maple Leaf Foods (TSX: MFI) yesterday hosted its 11th Food Safety Symposium in partnership with the Alliance to Stop Foodborne Illness (STOP Alliance) as part of the company's ongoing commitment to enhance food safety across the global food supply chain.
  • The annual Food Safety Symposium is a key Maple Leaf Foods initiative and part of the company's commitment to be a global food safety leader.
  • "Our annual Maple Leaf Foods Food Safety Symposium strives to create a collaborative atmosphere that engages people along the food supply chain, from the C-suite to front-line associates, in building a safer global food supply," said Randy Huffman, Ph.D., Chief Food Safety and Sustainability Officerat Maple Leaf Foods.
  • The Alliance to Stop Foodborne Illness is an initiative of Stop Foodborne Illness (STOP), leading food companies and organizations committed to the goal of preventing foodborne illness by utilizing compelling personal stories of individuals and families who have been impacted by a severe foodborne illness.

CallRail Announces Three Executive Team Hires To Advance Company's Meteoric Growth

Retrieved on: 
Thursday, October 21, 2021 - 2:00pm

With these three strategic new hires, CallRail is primed for continued growth in 2022 and beyond.

Key Points: 
  • With these three strategic new hires, CallRail is primed for continued growth in 2022 and beyond.
  • Lipscomb is a proud champion of small business growth, most recently at Cox Media and Cardlytics.
  • "We want tens of thousands of businesses to grow and thrive with CallRail," said Mary Pat Donnellon, Chief Revenue Officer at CallRail.
  • "Kimberly's wealth of expertise in revenue operations will directly and significantly advance CallRail's rapid growth trajectory.

WNC Appoints Sarah Arnold to Vice President - Asset Management

Retrieved on: 
Wednesday, September 29, 2021 - 3:05pm

IRVINE, Calif., Sept. 29, 2021 /PRNewswire/ -- WNC , a leading provider of investment, asset management and development services in the affordable housing industry, announced today that it has appointed Sarah Arnold as vice president - asset management.

Key Points: 
  • IRVINE, Calif., Sept. 29, 2021 /PRNewswire/ -- WNC , a leading provider of investment, asset management and development services in the affordable housing industry, announced today that it has appointed Sarah Arnold as vice president - asset management.
  • "Sarah is a seasoned professional with in-depth experience managing large portfolios of LIHTC properties, and we are pleased to welcome her to WNC's asset management team," said Kent Mehring, senior vice president of asset management at WNC.
  • She joins WNC from Wentwood Capital Advisors, where she spent approximately 13 years as vice president of asset management, focused on low-income housing tax credit properties.In this role, she was responsible for the oversight of approximately 70 LIHTC properties, including capital transactions and property-partnership restructurings.
  • WNC, founded in 1971 and headquartered in Irvine, Calif., is a national investor in affordable housing and community development initiatives.

Alzamend Neuro™ Announces Appointment of Dr. Eric McDade to Its Scientific Advisory Board

Retrieved on: 
Tuesday, July 16, 2019 - 7:43pm

Alzamend Neuro, Inc. (Alzamend or the Company) announced today that it had appointed Eric McDade, DO, a board-certified cognitive neurologist, as its next member to its Scientific Advisory Board.

Key Points: 
  • Alzamend Neuro, Inc. (Alzamend or the Company) announced today that it had appointed Eric McDade, DO, a board-certified cognitive neurologist, as its next member to its Scientific Advisory Board.
  • View the full release here: https://www.businesswire.com/news/home/20190716005944/en/
    Eric M. McDade, DO, a board-certified cognitive neurologist and Associate Director of the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU).
  • (Photo: Business Wire)
    Dr. McDade is the Associate Director of the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU).
  • Alzamend Neuro, Inc. is a Delaware corporation with its corporate headquarters in the State of Florida.